Acadia Pharmaceuticals (ACAD) just stacked two key clinical milestones: a fresh USPTO Notice of Allowance extending potential ...
Investment firm RBC said the patent litigation between Acadia Pharmaceuticals (ACAD) and generic drugmaker Zydus over Nuplazid appears to have been resolved. Shares of Acadia Pharmaceuticals turned ...
Here is how Acadia Healthcare (ACHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this ...
StockStory.org on MSN
Acadia Healthcare (ACHC): Buy, sell, or hold post Q2 earnings?
Acadia Healthcare trades at $28.83 and has moved in lockstep with the market. Its shares have returned 13.5% over the last ...
New nonprofit seeks $1 million in community support to secure the future of The Ellsworth American, Mount Desert Islander and ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Acadia Pharmaceuticals ( ACAD) sank almost 7% on Friday, closing at $20.68 after a drop of $1.50. This came after a 13% drop ...
The annual volunteer tradition brings community together to help protect Acadia’s historic carriage roads. Please register by ...
Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint, but the company and analysts alike ...
Acadia Realty Trust (ISIN US0042391096) announced a USD 60 million purchase of two SoHo storefronts on September 14, 2026, ...
Classic Chronicle heads to Acadia National Park in this 2002 segment, highlighting accessible hikes, trail history and ...
In a one of a kind promotion for Perkins Restaurant and Bakery, the iconic family-dining restaurant known for homestyle meals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results